India Vaccine Market Segments, Share, Size, Growth, Trends, Outlook & Forecast | 2024 - 2032

The India vaccine market is undergoing significant growth, driven by various factors, including the increasing burden of infectious diseases, rising demand for immunisation, and the growing focus on local vaccine production. As of 2023, the market was valued at INR 118.76 billion, with expectations of robust growth, projected to reach INR 278.53 billion by 2032, growing at a CAGR of 8.8% from 2024 to 2032. This market growth is propelled by the need for vaccinations across both the public and private healthcare sectors, along with strategic partnerships and technological advancements.

In this post, we will provide an in-depth analysis of the India vaccine market, discussing the market size, key players, growth drivers, emerging trends, and the impact of COVID-19. Additionally, we will examine the market segmentation, share, and regional outlook to help you understand the dynamics of the vaccine industry in India.

Get a Free Sample Report with Table of Contents: https://tinyurl.com/2xs63b22

Market Overview

The India vaccine market is a critical segment of the global healthcare industry, primarily due to the country's population size and the public health challenges it faces. India's vaccination program is one of the largest in the world, addressing a wide range of infectious diseases that affect millions of people each year. The rise in vaccine awareness, coupled with the government's strong support for immunisation, has significantly contributed to the market's expansion.

Vaccination has become a key focus in India's fight against diseases like polio, tuberculosis, hepatitis, and more recently, COVID-19. Alongside these, there is increasing adoption of vaccines for diseases such as influenza, pneumonia, and cervical cancer.

Market Size and Growth

As mentioned earlier, the India vaccine market was valued at INR 118.76 billion in 2023, with a forecasted growth rate of 8.8% CAGR during the period 2024-2032. The market is expected to reach INR 278.53 billion by 2032. This growth is attributed to several factors, including:

High Burden of Infectious Diseases: India remains one of the most populous countries in the world, and infectious diseases continue to pose a serious health risk. The government's emphasis on immunisation and vaccination programs plays a significant role in reducing disease incidence.

Government Initiatives and Policies: The Indian government has implemented various schemes like the Universal Immunisation Programme (UIP) to ensure widespread access to vaccines across the country. Moreover, strategic collaborations with global organisations like GAVI (Global Alliance for Vaccines and Immunisation) have further supported vaccine distribution and awareness.

Technological Advancements: Advancements in vaccine technology, including the development of new-generation vaccines and delivery systems, have enhanced vaccine efficacy and patient compliance. This includes the development of mRNA vaccines, especially for diseases like COVID-19.

Read Full Report with Table of Contents: https://tinyurl.com/29y3vgxo

Key Players in the India Vaccine Market

Several prominent players dominate the Indian vaccine market, contributing significantly to market development through innovation, strategic collaborations, and expanded manufacturing capacity. Some of the key players include:

Serum Institute of India Pvt. Ltd.
Based in Pune, Serum Institute of India is the largest vaccine manufacturer globally by the number of doses produced and sold. It has a diverse product portfolio catering to diseases like polio, measles, rubella, and COVID-19.

Bharat Biotech International Ltd.
Headquartered in Hyderabad, Bharat Biotech is a key player in the Indian vaccine industry, known for developing indigenous vaccines such as Covaxin for COVID-19. It also focuses on vaccines for infectious diseases like hepatitis, typhoid, and rotavirus.

Cadila Healthcare (Zydus Cadila)
Zydus Cadila, based in Ahmedabad, is another major vaccine producer in India. The company developed the ZyCoV-D vaccine, one of the first DNA vaccines for COVID-19. It also manufactures vaccines for polio, diphtheria, and more.

Panacea Biotec Ltd.
Based in New Delhi, Panacea Biotec manufactures a wide range of vaccines, including vaccines for hepatitis B, polio, and combination vaccines. The company has made significant strides in both domestic and international markets.

GlaxoSmithKline (GSK) Pharmaceuticals
While GSK is a global player, its presence in the Indian vaccine market is substantial, with vaccines targeting diseases like influenza, hepatitis, and pneumonia. GSK's strong distribution network in India contributes to its market share.

Merck & Co., Inc.
Merck is another global giant with a significant presence in the Indian vaccine market. The company focuses on vaccines for HPV, influenza, and pneumococcal diseases.

Sanofi Pasteur
A division of Sanofi, Sanofi Pasteur focuses on vaccines for both infectious diseases and global health initiatives. Their products are widely used in the Indian market, including vaccines for polio, hepatitis, and influenza.

Market Segmentation

The India vaccine market can be segmented based on vaccine type, end user, and distribution channel:

By Vaccine Type

Polio Vaccines
India has made tremendous progress in eradicating polio, thanks to extensive vaccination campaigns. Polio vaccines, including inactivated polio vaccine (IPV) and oral polio vaccine (OPV), continue to be a critical component of India's vaccination programs.

Influenza Vaccines
With seasonal outbreaks of influenza, the demand for influenza vaccines has seen steady growth. These vaccines are particularly essential for vulnerable groups such as the elderly, pregnant women, and children.

COVID-19 Vaccines
COVID-19 vaccines have seen widespread demand across India, with vaccines like Covishield and Covaxin playing a crucial role in the country's pandemic response.

Hepatitis Vaccines
Hepatitis B vaccination has been a key part of India's vaccination programme, as the country has a high burden of viral hepatitis.

By End User

Hospitals
Hospitals are the primary consumers of vaccines, especially for the immunisation of newborns, children, and adults. Hospitals also stock vaccines for diseases like hepatitis, influenza, and tuberculosis.

Government Healthcare Centres
Government health centres play a significant role in vaccination campaigns, ensuring that vaccines are accessible to the wider population, especially in rural and underserved regions.

Private Clinics
Private clinics, including paediatric and family physicians' offices, also contribute significantly to the vaccine market, with vaccines being administered to patients for diseases like influenza, HPV, and others.

By Distribution Channel

Direct Sales
Direct sales to government entities, healthcare centres, and hospitals constitute a large portion of vaccine distribution in India.

Retail Sales
Retail pharmacies and clinics play a growing role in vaccine distribution, with an increasing number of people opting for private immunisation services.

Emerging Trends in the Vaccine Market

Growth in mRNA Vaccines
The success of mRNA vaccines during the COVID-19 pandemic has opened the door for their use in other infectious diseases. Companies like Serum Institute and Bharat Biotech are likely to explore mRNA technologies for diseases like malaria and tuberculosis.

Focus on Preventive Vaccination
Preventive vaccines, particularly for diseases such as cancer (HPV vaccines), pneumonia, and influenza, are gaining more attention. India's growing middle-class population is increasingly focusing on preventative healthcare.

Increased Local Manufacturing
India's vaccine manufacturers are ramping up local production capabilities, especially for COVID-19 vaccines. This local manufacturing surge is helping to increase accessibility and reduce costs, further driving market growth.

Public-Private Partnerships
Collaborations between the Indian government and private companies are strengthening vaccine accessibility, especially in rural regions. These partnerships aim to increase immunisation coverage, reduce costs, and improve logistics.

Rising Vaccine Hesitancy
Despite widespread vaccine awareness, there is a growing issue of vaccine hesitancy in certain sections of the population. Educational campaigns and awareness programs are crucial in combating misinformation about vaccines.

COVID-19 Impact on the Vaccine Market

The COVID-19 pandemic significantly impacted the India vaccine market, both in terms of demand and supply. The need for COVID-19 vaccines resulted in a massive surge in production and distribution, with India emerging as one of the largest producers of vaccines. Both Covaxin (developed by Bharat Biotech) and Covishield (developed by Serum Institute) played pivotal roles in the global fight against the pandemic.

While the pandemic slowed the routine vaccination schedules for other diseases, it also led to significant advancements in vaccine technology, including the rapid development of mRNA vaccines. The shift towards digital health and vaccination tracking also accelerated as a result of the pandemic.

Market Outlook

The future of the vaccine market in India is highly promising, with significant growth expected in the coming years. The increasing prevalence of infectious diseases, combined with government efforts to ensure universal immunisation, will drive market expansion. Additionally, advancements in vaccine technology, such as DNA and mRNA vaccines, will further strengthen India's position in the global vaccine market.

In particular, the government's focus on increasing local production and distribution networks will further enhance access to vaccines in remote and underserved regions. As India continues to develop its healthcare infrastructure, the vaccine market will likely benefit from greater investment and technological innovation.

Frequently Asked Questions (FAQs)

1. What are the major drivers of the India vaccine market?
The primary drivers include the high burden of infectious diseases, increased focus on immunisation programs, government support, rising vaccine awareness, and advancements in vaccine technology.

2. Who are the leading players in the India vaccine market?
Key players include Serum Institute of India, Bharat Biotech, Cadila Healthcare, Panacea Biotec, GlaxoSmithKline, Merck & Co., and Sanofi Pasteur.

3. What is the forecast for the India vaccine market growth?
The market is expected to grow at a CAGR of 8.8%, reaching INR 278.53 billion by 2032.

4. How has COVID-19 impacted the India vaccine market?
COVID-19 led to a surge in vaccine production and distribution, with a particular focus on COVID-19 vaccines. It also accelerated advancements in vaccine technology and digital health solutions.

5. What are the key trends in the India vaccine market?
Key trends include the rise of mRNA vaccines, increased local manufacturing, public-private partnerships, and growing vaccine hesitancy.

Related Trending Reports

Global Cancer Screening Market : https://tinyurl.com/26ajosfe
Global Cryotherapy Market : https://tinyurl.com/296q7s35
Asia Pacific Anti-Obesity Drugs Market : https://tinyurl.com/296q7s35
Global Automatic Cell Imaging System Market : https://tinyurl.com/22336925

Media Contact :

Company Name: Claight Corporation
Contact Person: James william, Corporate Sales Specialist
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.